Does TRIPROLIDINE Cause Mobility decreased? 102 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 102 reports of Mobility decreased have been filed in association with TRIPROLIDINE (Childrens PediaClear PD). This represents 60.0% of all adverse event reports for TRIPROLIDINE.
102
Reports of Mobility decreased with TRIPROLIDINE
60.0%
of all TRIPROLIDINE reports
26
Deaths
27
Hospitalizations
How Dangerous Is Mobility decreased From TRIPROLIDINE?
Of the 102 reports, 26 (25.5%) resulted in death, 27 (26.5%) required hospitalization, and 102 (100.0%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRIPROLIDINE. However, 102 reports have been filed with the FAERS database.
What Other Side Effects Does TRIPROLIDINE Cause?
Psoriatic arthropathy (110)
Type 2 diabetes mellitus (109)
Pericarditis (108)
Joint swelling (106)
Oedema (106)
Pemphigus (105)
Pyrexia (105)
Sinusitis (104)
Urticaria (103)
Injury (102)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which TRIPROLIDINE Alternatives Have Lower Mobility decreased Risk?
TRIPROLIDINE vs TRIPTORELIN
TRIPROLIDINE vs TRISODIUM
TRIPROLIDINE vs TROFINETIDE
TRIPROLIDINE vs TROFOSFAMIDE
TRIPROLIDINE vs TROPATEPINE